Ultralife Corporation (ULBI)
NASDAQ: ULBI · Real-Time Price · USD
6.84
-0.15 (-2.15%)
Sep 9, 2025, 12:53 PM - Market open

Ultralife Statistics

Total Valuation

Ultralife has a market cap or net worth of $113.84 million. The enterprise value is $157.09 million.

Market Cap113.84M
Enterprise Value 157.09M

Important Dates

The next estimated earnings date is Friday, November 7, 2025, before market open.

Earnings Date Nov 7, 2025
Ex-Dividend Date n/a

Share Statistics

Ultralife has 16.64 million shares outstanding. The number of shares has increased by 1.73% in one year.

Current Share Class 16.64M
Shares Outstanding 16.64M
Shares Change (YoY) +1.73%
Shares Change (QoQ) -0.14%
Owned by Insiders (%) 36.70%
Owned by Institutions (%) 37.10%
Float 10.54M

Valuation Ratios

The trailing PE ratio is 36.37.

PE Ratio 36.37
Forward PE n/a
PS Ratio 0.65
Forward PS 0.51
PB Ratio 0.84
P/TBV Ratio 1.64
P/FCF Ratio 8.15
P/OCF Ratio 6.63
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 12.15, with an EV/FCF ratio of 11.30.

EV / Earnings 49.15
EV / Sales 0.88
EV / EBITDA 12.15
EV / EBIT 19.68
EV / FCF 11.30

Financial Position

The company has a current ratio of 3.31, with a Debt / Equity ratio of 0.39.

Current Ratio 3.31
Quick Ratio 1.45
Debt / Equity 0.39
Debt / EBITDA 3.86
Debt / FCF 3.93
Interest Coverage 2.64

Financial Efficiency

Return on equity (ROE) is 2.40% and return on invested capital (ROIC) is 2.91%.

Return on Equity (ROE) 2.40%
Return on Assets (ROA) 2.55%
Return on Invested Capital (ROIC) 2.91%
Return on Capital Employed (ROCE) 4.18%
Revenue Per Employee $266,547
Profits Per Employee $4,763
Employee Count671
Asset Turnover 0.92
Inventory Turnover 2.94

Taxes

In the past 12 months, Ultralife has paid $1.15 million in taxes.

Income Tax 1.15M
Effective Tax Rate 26.00%

Stock Price Statistics

The stock price has decreased by -24.27% in the last 52 weeks. The beta is 1.08, so Ultralife's price volatility has been similar to the market average.

Beta (5Y) 1.08
52-Week Price Change -24.27%
50-Day Moving Average 7.84
200-Day Moving Average 6.88
Relative Strength Index (RSI) 45.82
Average Volume (20 Days) 51,669

Short Selling Information

The latest short interest is 163,822, so 0.98% of the outstanding shares have been sold short.

Short Interest 163,822
Short Previous Month 187,006
Short % of Shares Out 0.98%
Short % of Float 1.55%
Short Ratio (days to cover) 2.66

Income Statement

In the last 12 months, Ultralife had revenue of $178.85 million and earned $3.20 million in profits. Earnings per share was $0.19.

Revenue178.85M
Gross Profit 43.71M
Operating Income 7.98M
Pretax Income 12.33M
Net Income 3.20M
EBITDA 12.93M
EBIT 7.98M
Earnings Per Share (EPS) $0.19
Full Income Statement

Balance Sheet

The company has $10.94 million in cash and $54.69 million in debt, giving a net cash position of -$43.75 million or -$2.63 per share.

Cash & Cash Equivalents 10.94M
Total Debt 54.69M
Net Cash -43.75M
Net Cash Per Share -$2.63
Equity (Book Value) 138.65M
Book Value Per Share 8.32
Working Capital 69.11M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was $17.10 million and capital expenditures -$3.20 million, giving a free cash flow of $13.90 million.

Operating Cash Flow 17.10M
Capital Expenditures -3.20M
Free Cash Flow 13.90M
FCF Per Share $0.84
Full Cash Flow Statement

Margins

Gross margin is 24.44%, with operating and profit margins of 4.46% and 1.79%.

Gross Margin 24.44%
Operating Margin 4.46%
Pretax Margin 2.46%
Profit Margin 1.79%
EBITDA Margin 7.23%
EBIT Margin 4.46%
FCF Margin 7.77%

Dividends & Yields

Ultralife does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -1.73%
Shareholder Yield -1.73%
Earnings Yield 2.82%
FCF Yield 12.26%

Analyst Forecast

The average price target for Ultralife is $14.00, which is 104.68% higher than the current price. The consensus rating is "Strong Buy".

Price Target $14.00
Price Target Difference 104.68%
Analyst Consensus Strong Buy
Analyst Count 1
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Ultralife has an Altman Z-Score of 2.05 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score 2.05
Piotroski F-Score 4